Jelili Ojodu

1.6k total citations
36 papers, 869 citations indexed

About

Jelili Ojodu is a scholar working on Clinical Biochemistry, Pediatrics, Perinatology and Child Health and Genetics. According to data from OpenAlex, Jelili Ojodu has authored 36 papers receiving a total of 869 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Clinical Biochemistry, 12 papers in Pediatrics, Perinatology and Child Health and 11 papers in Genetics. Recurrent topics in Jelili Ojodu's work include Metabolism and Genetic Disorders (20 papers), Hemoglobinopathies and Related Disorders (6 papers) and Genomics and Rare Diseases (5 papers). Jelili Ojodu is often cited by papers focused on Metabolism and Genetic Disorders (20 papers), Hemoglobinopathies and Related Disorders (6 papers) and Genomics and Rare Diseases (5 papers). Jelili Ojodu collaborates with scholars based in United States and United Kingdom. Jelili Ojodu's co-authors include W. Harry Hannon, Sikha Singh, Mary Hulihan, Alex R. Kemper, Scott D. Grosse, Anne Marie Comeau, Althea M. Grant, Susan Tanksley, Lisa A. Prosser and Wendy K. K. Lam and has published in prestigious journals such as Blood, PLoS ONE and PEDIATRICS.

In The Last Decade

Jelili Ojodu

34 papers receiving 828 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jelili Ojodu United States 16 292 263 223 214 213 36 869
Lisa Feuchtbaum United States 22 370 1.3× 493 1.9× 246 1.1× 257 1.2× 195 0.9× 39 1.2k
Steven J. Culbert United States 17 100 0.3× 182 0.7× 102 0.5× 118 0.6× 152 0.7× 38 898
Marie‐Hélène Odièvre France 14 145 0.5× 95 0.4× 324 1.5× 266 1.2× 27 0.1× 46 830
Choni Rinat Israel 18 83 0.3× 174 0.7× 53 0.2× 498 2.3× 151 0.7× 39 1.1k
A. R. Al-Swailem Saudi Arabia 13 38 0.1× 127 0.5× 268 1.2× 93 0.4× 126 0.6× 32 728
P. Donnai United Kingdom 16 53 0.2× 494 1.9× 41 0.2× 145 0.7× 156 0.7× 40 1.0k
Hassan El Solh Saudi Arabia 15 26 0.1× 194 0.7× 77 0.3× 192 0.9× 42 0.2× 33 641
Guido F. Laube Switzerland 20 25 0.1× 449 1.7× 39 0.2× 377 1.8× 79 0.4× 48 1.4k
I. B. Houston United Kingdom 14 44 0.2× 106 0.4× 92 0.4× 148 0.7× 66 0.3× 38 677
Franziska Grundmann Germany 14 16 0.1× 53 0.2× 150 0.7× 196 0.9× 91 0.4× 53 964

Countries citing papers authored by Jelili Ojodu

Since Specialization
Citations

This map shows the geographic impact of Jelili Ojodu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jelili Ojodu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jelili Ojodu more than expected).

Fields of papers citing papers by Jelili Ojodu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jelili Ojodu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jelili Ojodu. The network helps show where Jelili Ojodu may publish in the future.

Co-authorship network of co-authors of Jelili Ojodu

This figure shows the co-authorship network connecting the top 25 collaborators of Jelili Ojodu. A scholar is included among the top collaborators of Jelili Ojodu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jelili Ojodu. Jelili Ojodu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ream, Margie, Wendy K. K. Lam, Scott D. Grosse, et al.. (2025). Evidence and Recommendation for Infantile Krabbe Disease Newborn Screening. PEDIATRICS. 155(4). 1 indexed citations
2.
Kemper, Alex R., Wendy K. K. Lam, Jelili Ojodu, et al.. (2025). Evidence Regarding Duchenne Muscular Dystrophy Newborn Screening. PEDIATRICS.
3.
Gaviglio, Amy, et al.. (2023). Infants with Congenital Diseases Identified through Newborn Screening—United States, 2018–2020. International Journal of Neonatal Screening. 9(2). 23–23. 7 indexed citations
4.
Olney, Richard S., et al.. (2023). 2023 APHL/ISNS Newborn Screening Symposium. International Journal of Neonatal Screening. 9(4). 54–54. 4 indexed citations
5.
Ream, Margie, Wendy K. K. Lam, Scott D. Grosse, et al.. (2022). Evidence and recommendation for mucopolysaccharidosis type II newborn screening in the United States. Genetics in Medicine. 25(2). 100330–100330. 7 indexed citations
6.
Johnson, Carol, et al.. (2021). Establishing a National Community of Practice for Newborn Screening Follow-Up. International Journal of Neonatal Screening. 7(3). 49–49. 5 indexed citations
7.
Sontag, Marci K., Josh Miller, Sikha Singh, et al.. (2020). Newborn screening timeliness quality improvement initiative: Impact of national recommendations and data repository. PLoS ONE. 15(4). e0231050–e0231050. 27 indexed citations
8.
Kellar‐Guenther, Yvonne, et al.. (2020). Implementing Statewide Newborn Screening for New Disorders: U.S. Program Experiences. International Journal of Neonatal Screening. 6(2). 35–35. 18 indexed citations
9.
Kellar‐Guenther, Yvonne, et al.. (2020). Expanding Newborn Screening for Pompe Disease in the United States: The NewSTEPs New Disorders Implementation Project, a Resource for New Disorder Implementation. International Journal of Neonatal Screening. 6(2). 48–48. 9 indexed citations
10.
11.
Sontag, Marci K., Scott D. Grosse, Josh Miller, et al.. (2020). Infants with Congenital Disorders Identified Through Newborn Screening — United States, 2015–2017. MMWR Morbidity and Mortality Weekly Report. 69(36). 1265–1268. 38 indexed citations
12.
Sontag, Marci K., Josh Miller, Yvonne Kellar‐Guenther, et al.. (2019). Development of National Newborn Screening Quality Indicators in the United States. International Journal of Neonatal Screening. 5(3). 34–34. 11 indexed citations
13.
Kellar‐Guenther, Yvonne, et al.. (2019). Analyzing Patterns in NewSTEPs Site Review Recommendations: Practical Applications for Newborn Screening Programs. International Journal of Neonatal Screening. 5(1). 13–13. 4 indexed citations
14.
Kemper, Alex R., Jeffrey P. Brosco, Anne Marie Comeau, et al.. (2016). Newborn screening for X-linked adrenoleukodystrophy: evidence summary and advisory committee recommendation. Genetics in Medicine. 19(1). 121–126. 79 indexed citations
15.
Shapira, Stuart K., Cynthia F. Hinton, Patrice K. Held, et al.. (2015). Single newborn screen or routine second screening for primary congenital hypothyroidism. Molecular Genetics and Metabolism. 116(3). 125–132. 18 indexed citations
16.
Held, Patrice K., Stuart K. Shapira, Cynthia F. Hinton, et al.. (2015). Congenital adrenal hyperplasia cases identified by newborn screening in one- and two-screen states. Molecular Genetics and Metabolism. 116(3). 133–138. 25 indexed citations
17.
Ojodu, Jelili, et al.. (2014). Incidence of sickle cell trait--United States, 2010.. PubMed. 63(49). 1155–8. 114 indexed citations
18.
19.
Therrell, Bradford L., W. Harry Hannon, Gary Hoffman, Jelili Ojodu, & Philip M. Farrell. (2012). Immunoreactive trypsinogen (IRT) as a biomarker for cystic fibrosis: Challenges in newborn dried blood spot screening. Molecular Genetics and Metabolism. 106(1). 1–6. 41 indexed citations
20.
Olney, Richard S., Cynthia A. Moore, Jelili Ojodu, Mary Lou Lindegren, & W. Harry Hannon. (2006). Storage and use of residual dried blood spots from state newborn screening programs. The Journal of Pediatrics. 148(5). 618–622. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lisa Feuchtbaum Breakdown of academic impact, for papers by Steven J. Culbert Breakdown of academic impact, for papers by Marie‐Hélène Odièvre Breakdown of academic impact, for papers by Choni Rinat Breakdown of academic impact, for papers by A. R. Al-Swailem Breakdown of academic impact, for papers by P. Donnai Breakdown of academic impact, for papers by Hassan El Solh Breakdown of academic impact, for papers by Guido F. Laube Breakdown of academic impact, for papers by I. B. Houston Breakdown of academic impact, for papers by Franziska Grundmann
Rankless by CCL
2026